Aprepitant was approved for medical use in Europe and the United States in 2003.[1][3] It is made by Merck & Co.[1] It is on the World Health Organization's List of Essential Medicines.[4] A form that can be given by injection into a vein, known as fosaprepitant is also available.[1]